208 related articles for article (PubMed ID: 25644496)
1. ANGPTL3 is a novel biomarker as it activates ERK/MAPK pathway in oral cancer.
Koyama T; Ogawara K; Kasamatsu A; Okamoto A; Kasama H; Minakawa Y; Shimada K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
Cancer Med; 2015 May; 4(5):759-69. PubMed ID: 25644496
[TBL] [Abstract][Full Text] [Related]
2. Persephin: A potential key component in human oral cancer progression through the RET receptor tyrosine kinase-mitogen-activated protein kinase signaling pathway.
Baba T; Sakamoto Y; Kasamatsu A; Minakawa Y; Yokota S; Higo M; Yokoe H; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
Mol Carcinog; 2015 Aug; 54(8):608-17. PubMed ID: 24375483
[TBL] [Abstract][Full Text] [Related]
3. Annexin A10 in human oral cancer: biomarker for tumoral growth via G1/S transition by targeting MAPK signaling pathways.
Shimizu T; Kasamatsu A; Yamamoto A; Koike K; Ishige S; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2012; 7(9):e45510. PubMed ID: 23029062
[TBL] [Abstract][Full Text] [Related]
4. Cavin-2 in oral cancer: A potential predictor for tumor progression.
Unozawa M; Kasamatsu A; Higo M; Fukumoto C; Koyama T; Sakazume T; Nakashima D; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
Mol Carcinog; 2016 Jun; 55(6):1037-47. PubMed ID: 26086332
[TBL] [Abstract][Full Text] [Related]
5. Semaphorin7A Promotion of Tumoral Growth and Metastasis in Human Oral Cancer by Regulation of G1 Cell Cycle and Matrix Metalloproteases: Possible Contribution to Tumoral Angiogenesis.
Saito T; Kasamatsu A; Ogawara K; Miyamoto I; Saito K; Iyoda M; Suzuki T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(9):e0137923. PubMed ID: 26378920
[TBL] [Abstract][Full Text] [Related]
6. Upregulation of B-cell translocation gene 2 by epigallocatechin-3-gallate via p38 and ERK signaling blocks cell proliferation in human oral squamous cell carcinoma cells.
Lee JC; Chung LC; Chen YJ; Feng TH; Chen WT; Juang HH
Cancer Lett; 2015 May; 360(2):310-8. PubMed ID: 25721086
[TBL] [Abstract][Full Text] [Related]
7. Epithelial cell transforming sequence 2 in human oral cancer.
Iyoda M; Kasamatsu A; Ishigami T; Nakashima D; Endo-Sakamoto Y; Ogawara K; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2010 Nov; 5(11):e14082. PubMed ID: 21124766
[TBL] [Abstract][Full Text] [Related]
8. miRNA-491-5p and GIT1 serve as modulators and biomarkers for oral squamous cell carcinoma invasion and metastasis.
Huang WC; Chan SH; Jang TH; Chang JW; Ko YC; Yen TC; Chiang SL; Chiang WF; Shieh TY; Liao CT; Juang JL; Wang HC; Cheng AJ; Lu YC; Wang LH
Cancer Res; 2014 Feb; 74(3):751-64. PubMed ID: 24335959
[TBL] [Abstract][Full Text] [Related]
9. Lysophosphatidylcholine acyltransferase1 overexpression promotes oral squamous cell carcinoma progression via enhanced biosynthesis of platelet-activating factor.
Shida-Sakazume T; Endo-Sakamoto Y; Unozawa M; Fukumoto C; Shimada K; Kasamatsu A; Ogawara K; Yokoe H; Shiiba M; Tanzawa H; Uzawa K
PLoS One; 2015; 10(3):e0120143. PubMed ID: 25803864
[TBL] [Abstract][Full Text] [Related]
10. UBE2S associated with OSCC proliferation by promotion of P21 degradation via the ubiquitin-proteasome system.
Yoshimura S; Kasamatsu A; Nakashima D; Iyoda M; Kasama H; Saito T; Takahara T; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Apr; 485(4):820-825. PubMed ID: 28257844
[TBL] [Abstract][Full Text] [Related]
11. High expression of S-phase kinase-interacting protein 2, human F-box protein, correlates with poor prognosis in oral squamous cell carcinomas.
Kudo Y; Kitajima S; Sato S; Miyauchi M; Ogawa I; Takata T
Cancer Res; 2001 Oct; 61(19):7044-7. PubMed ID: 11585732
[TBL] [Abstract][Full Text] [Related]
12. Calreticulin, an endoplasmic reticulum-resident protein, is highly expressed and essential for cell proliferation and migration in oral squamous cell carcinoma.
Chiang WF; Hwang TZ; Hour TC; Wang LH; Chiu CC; Chen HR; Wu YJ; Wang CC; Wang LF; Chien CY; Chen JH; Hsu CT; Chen JY
Oral Oncol; 2013 Jun; 49(6):534-41. PubMed ID: 23375593
[TBL] [Abstract][Full Text] [Related]
13. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
14. Novel mechanism of aberrant ZIP4 expression with zinc supplementation in oral tumorigenesis.
Ishida S; Kasamatsu A; Endo-Sakamoto Y; Nakashima D; Koide N; Takahara T; Shimizu T; Iyoda M; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2017 Jan; 483(1):339-345. PubMed ID: 28017725
[TBL] [Abstract][Full Text] [Related]
15. Overexpression of CDCA2 in human squamous cell carcinoma: correlation with prevention of G1 phase arrest and apoptosis.
Uchida F; Uzawa K; Kasamatsu A; Takatori H; Sakamoto Y; Ogawara K; Shiiba M; Bukawa H; Tanzawa H
PLoS One; 2013; 8(2):e56381. PubMed ID: 23418564
[TBL] [Abstract][Full Text] [Related]
16. p21WAF1/CIP1 expression is a marker of poor prognosis in oral squamous cell carcinoma.
Nemes JA; Nemes Z; Márton IJ
J Oral Pathol Med; 2005 May; 34(5):274-9. PubMed ID: 15817070
[TBL] [Abstract][Full Text] [Related]
17. S100A16 promotes differentiation and contributes to a less aggressive tumor phenotype in oral squamous cell carcinoma.
Sapkota D; Bruland O; Parajuli H; Osman TA; Teh MT; Johannessen AC; Costea DE
BMC Cancer; 2015 Sep; 15():631. PubMed ID: 26353754
[TBL] [Abstract][Full Text] [Related]
18. Hyaluronan-mediated motility: a target in oral squamous cell carcinoma.
Yamano Y; Uzawa K; Shinozuka K; Fushimi K; Ishigami T; Nomura H; Ogawara K; Shiiba M; Yokoe H; Tanzawa H
Int J Oncol; 2008 May; 32(5):1001-9. PubMed ID: 18425326
[TBL] [Abstract][Full Text] [Related]
19. UNC93B1 promotes tumoral growth by controlling the secretion level of granulocyte macrophage colony-stimulating factor in human oral cancer.
Wagai S; Kasamatsu A; Iyoda M; Hayashi F; Hiroshima K; Yoshimura S; Miyamoto I; Nakashima D; Endo-Sakamoto Y; Shiiba M; Tanzawa H; Uzawa K
Biochem Biophys Res Commun; 2019 May; 513(1):81-87. PubMed ID: 30935694
[TBL] [Abstract][Full Text] [Related]
20. Aberrant expression of histone deacetylase 6 in oral squamous cell carcinoma.
Sakuma T; Uzawa K; Onda T; Shiiba M; Yokoe H; Shibahara T; Tanzawa H
Int J Oncol; 2006 Jul; 29(1):117-24. PubMed ID: 16773191
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
